Pathak, N., Cheruku, S. P., Rao, V., Vibhavari, R. J. A., Sumalatha, S., Gourishetti, K., . . . Kumar, N. (2020). Dehydrozingerone protects temozolomide-induced cognitive impairment in normal and C6 glioma rats besides enhancing its anticancer potential. 3 Biotech.

Pathak, Nandini, Sri Pragnya Cheruku, Vanishree Rao, R. J. A. Vibhavari, Suhani Sumalatha, Karthik Gourishetti, C. Mallikarjuna Rao, and Nitesh Kumar. "Dehydrozingerone Protects Temozolomide-induced Cognitive Impairment in Normal and C6 Glioma Rats Besides Enhancing Its Anticancer Potential." 3 Biotech 2020.

Pathak, Nandini, et al. "Dehydrozingerone Protects Temozolomide-induced Cognitive Impairment in Normal and C6 Glioma Rats Besides Enhancing Its Anticancer Potential." 3 Biotech 2020.